ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.940
-0.180 (-5.77%)
At close: Nov 7, 2025
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €47.37 million as of November 10, 2025. Its market cap has increased by 2.80% in one year.
Market Cap
47.37M
Enterprise Value
49.14M
Revenue
6.23M
Ranking
n/a
PE Ratio
102.24
Stock Price
€2.94
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 47.37M, an increase of 1,788.88%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 47.37M | 19.51% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |